For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Experts in the care of newborn babies have presented what they say is 'significant new medical evidence' in Lucy Letby's case ...

WashingtonSANA-A new study highlighted the potential benefits of popular diabetes drugs on a wide range of health issues including demen ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.